This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Graco (GGG) Surpasses Earnings and Sales Estimates in Q3
by Zacks Equity Research
Graco's (GGG) third-quarter earnings reflect gains from healthy sales generation (driven by growth in the Contractor segment), improved margins and lower taxes.
Buy 5 Manufacturing Stocks Ahead of Q3 Earnings Next Week
by Nalak Das
Five manufacturing stocks namely, Stanley Black & Decker(SWK), Franklin Electric (FELE), IDEX (IEX), John Bean Technologies (JBT) and Regal Beloit (RBC) are set to beat on Q3 earnings next week.
Idex (IEX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Idex (IEX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRobot (IRBT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
iRobot's (IRBT) Q3 results might reflect a healthy demand for products, a surge in e-commerce and improved international businesses. Pandemic woes and promotional expenses are to ail.
EnPro (NPO) Shares Gain 20% in 3 Months: What's Driving It?
by Zacks Equity Research
EnPro (NPO) benefits from its focus on restructuring portfolio, expertise in material science, cost-management actions and other growth-oriented initiatives.
Graco (GGG) Shares Gain 29% in 3 Months: What's Driving It?
by Zacks Equity Research
Graco (GGG), with a 29% rise in shares in the past three months, benefits from a solid product portfolio, product launches and the reviving U.S. manufacturing activities.
Altra Industrial Gains 30% in 3 Months: What's Driving It?
by Zacks Equity Research
Altra Industrial (AIMC), with a 30% rise in shares in the past three months, benefits from end-market opportunities, e-commerce capabilities, supply-chain initiatives and solid product offerings.
Nordson Arm Unveils Optimum Class VI Dispensing Components
by Zacks Equity Research
Nordson's (NDSN) Optimum Class VI fluid dispensing components help manufacturers in the medical industry to simplify process validation.
IDEX's Diversified Businesses & Buyouts to Aid Amid Pandemic
by Zacks Equity Research
IDEX's (IEX) diversified product offerings, presence in multiple markets, acquired assets and cost-saving measures might aid performances in the quarters ahead. The pandemic-led headwinds persist.
Idex (IEX) Up 4.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Near-Term Outlook Bleak for Industrial Manufacturing Stocks
by Zacks Equity Research
The Manufacturing - General Industrial industry is facing the coronavirus scares, escalating costs and other issues. Higher orders and recovery in manufacturing activities will likely benefit.
FLS vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FLS vs. IEX: Which Stock Is the Better Value Option?
IDEX (IEX) Q2 Earnings & Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
IDEX's (IEX) second-quarter 2020 revenues decline 12.6% year over year on account of lackluster performance across all of its segments.
Idex (IEX) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 8.91% and 6.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Graco (GGG) Earnings Surpass Estimates in Q2, Decline Y/Y
by Zacks Equity Research
Graco's (GGG) second-quarter earnings ail from poor revenue generation and decline in margins. The company is making efforts to sail through the uncertainties related to the pandemic.
Cintas (CTAS) Q4 Earnings & Sales Beat Estimates, Fall Y/Y
by Zacks Equity Research
Cintas' (CTAS) Q4 results suffer from weak organic sales and a fall in margins. Wary of the pandemic-related uncertainties, it refrains from providing projections for fiscal 2021.
iRobot (IRBT) Beats on Q2 Earnings, Hikes View for 2020
by Zacks Equity Research
iRobot's (IRBT) second-quarter 2020 earnings gain from solid demand for Roomba and Braava products, expense management, and tariff exclusion. Sales prospects are anticipated to improve in 2020.
Reasons Why Avoiding Barnes' (B) Stock is Preferable Now
by Zacks Equity Research
Barnes' (B) Industrial and Aerospace segments suffer from the pandemic-related restrictions and uncertainties. It expects organic sales to have declined in second-quarter 2020.
Analysts Estimate Idex (IEX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PH or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
PH or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
PH vs. IEX: Which Stock Is the Better Value Option?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
Colfax (CFX) Declines 23% YTD: What's Hurting the Stock?
by Zacks Equity Research
Colfax (CFX), with a 23% decline in shares so far in 2020, faces the adverse impacts of the pandemic. High debts and forex woes are other concerns. However, cost-reduction actions might aid.
Idex (IEX) Down 1.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kennametal's (KMT) Near-Term Prospects Bleak on Pandemic Woes
by Zacks Equity Research
Kennametal (KMT) will likely continue suffering from the operational and end-market uncertainties caused by the pandemic. Forex woes and restructuring charges are other concerns.